These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6773632)

  • 61. Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment.
    Adami S; Frijlink WB; Bijvoet OL; O'Riordan JL; Clemens TL; Papapoulos SE
    Calcif Tissue Int; 1982 Jul; 34(4):317-20. PubMed ID: 6814718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of retinoic acid on bone formation and resorption in cultured mouse calvaria.
    Togari A; Kondo M; Arai M; Matsumoto S
    Gen Pharmacol; 1991; 22(2):287-92. PubMed ID: 2055423
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
    Harinck HI; Papapoulos SE; Blanksma HJ; Moolenaar AJ; Vermeij P; Bijvoet OL
    Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1301-5. PubMed ID: 3120987
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of fasting, feeding, and bisphosphonate administration on serum calcitriol levels in phosphate-deprived rats.
    Felsenfeld AJ; Jara A; Avedian G; Kleeman CR
    Kidney Int; 2000 Sep; 58(3):1016-22. PubMed ID: 10972666
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of aminobisphosphonate infusion on biochemical indices of bone metabolism in rheumatoid arthritis.
    Tan PL; Ames R; Yeoman S; Ibbertson HK; Caughey DE
    Br J Rheumatol; 1989 Aug; 28(4):325-8. PubMed ID: 2787185
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.
    Flanagan AM; Chambers TJ
    Calcif Tissue Int; 1991 Dec; 49(6):407-15. PubMed ID: 1840176
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of long-term low-dose diphosphonate treatment on rat bone.
    Evans RA; Howlett CR; Dunstan CR; Hills E
    Clin Orthop Relat Res; 1982 May; (165):290-9. PubMed ID: 6210482
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
    Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
    J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A single infusion of Pamidronate (APD) in Paget's disease of bone].
    Thiébaud D; Jaeger P; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1989 Jan; 119(3):71-4. PubMed ID: 2711157
    [TBL] [Abstract][Full Text] [Related]  

  • 70. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
    Mühlbauer RC; Bauss F; Schenk R; Janner M; Bosies E; Strein K; Fleisch H
    J Bone Miner Res; 1991 Sep; 6(9):1003-11. PubMed ID: 1838661
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
    Body JJ; Dumon JC; Gineyts E; Delmas PD
    Br J Cancer; 1997; 75(3):408-12. PubMed ID: 9020487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aminobisphosphonate inhibition of interleukin-1-induced bone resorption in mouse calvariae.
    Tan PL; Katz JM; Ames R; Caughey DE; Gray HD; Ibbertson HK; Watson JD
    Arthritis Rheum; 1988 Jun; 31(6):762-8. PubMed ID: 3260101
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bisphosphonate space measurement in Paget's disease of bone treated with APD.
    Stone MD; Marshall DH; Hosking DJ; Perkins AC; Evans AJ; Wastie ML
    J Bone Miner Res; 1992 Mar; 7(3):295-301. PubMed ID: 1316715
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects.
    Russell RG; Fleisch H
    Clin Orthop Relat Res; 1975 May; (108):241-63. PubMed ID: 166785
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro.
    Tenenbaum HC; Torontali M; Sukhu B
    Bone; 1992; 13(3):249-55. PubMed ID: 1637572
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
    Reid IR; King AR; Alexander CJ; Ibbertson HK
    Lancet; 1988 Jan; 1(8578):143-6. PubMed ID: 2892989
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group.
    Boonekamp PM; Löwik CW; van der Wee-Pals LJ; van Wijk-van Lennep ML; Bijvoet OL
    Bone Miner; 1987 Feb; 2(1):29-42. PubMed ID: 3504722
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.
    Schenk R; Eggli P; Fleisch H; Rosini S
    Calcif Tissue Int; 1986 Jun; 38(6):342-9. PubMed ID: 3089557
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.
    Miller SC; Jee WS
    Anat Rec; 1979 Mar; 193(3):439-62. PubMed ID: 154858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.